This Order may be cited as the Medicines and Healthcare Products Regulatory Agency Trading Fund (Amendment) Order 2005 and shall come into force on 1st September 2005.

In this Order—

• “device evaluation services” means services consisting of or relating to the evaluation of medical devices or similar devices, or the components of such devices, for the purpose of determining—

  1. i

     the performance of those devices or components,

  2. ii

     the ease with which they can be used,

  3. iii

     whether they are suitable for use in different environments or for different purposes, or

  4. iv

     how the safety and performance of one device or component compares with that of other devices or components intended for use for the same purpose;

• “the fund” means the trading fund established by article 2 of the principal Order;

• “medical device” shall have the meaning given by regulation 2(1) of the Medical Devices Regulations 20027; and

• “the principal Order” means the Medicines and Healthcare Products Regulatory Agency Trading Fund Order 2003.